Fetal indusium griseum is a possible biomarker of the regularity of brain midline development in 3T MR imaging: A retrospective observational study.
Ivana PogledicMihaela Bobić-RasonjaChristian MitterAndrija ŠtajduharErnst SchwartzMarija Milković-PerišaPascal A BaltzerMaarten LequinElisabeth Krampl-BettelheimGregor KasprianMiloš JudašDaniela PrayerNataša Jovanov MiloševićPublished in: Acta obstetricia et gynecologica Scandinavica (2024)
The knowledge of developmental brain histology and fetal age allows us to predict the IG-visibility in magnetic resonance imaging (MRI) and use it as a biomarker to evaluate the morphogenesis of the brain midline. As a biomarker, IG is significant for post-mortem pathological examination by MRI. Therefore, in the clinical in vivo imaging examination, IG should be anticipated when an assessment of the brain midline structures is needed in mid-gestation, including corpus callosum thickness measurements.
Keyphrases
- magnetic resonance imaging
- resting state
- contrast enhanced
- white matter
- functional connectivity
- high resolution
- cerebral ischemia
- computed tomography
- diffusion weighted imaging
- preterm infants
- multiple sclerosis
- magnetic resonance
- optical coherence tomography
- mass spectrometry
- photodynamic therapy
- brain injury
- subarachnoid hemorrhage
- fluorescence imaging